Summary
The Institute for Neurodegenerative Diseases (IMN) in Bordeaux (France) combines basic research, preclinical and clinical research in the context of neurodegenerative diseases, particularly in Parkinson's disease. This disease, whose origin is not known, affects 150,000 people in France. Researchers of this institute explain its mechanism and treatments that exist as the drug L-Dopa.
They offer a solution for deep brain surgery simulation currently practiced in the Pellegrin Hospital. This was developed in 1993 by Dr. Christian Gross, DR. Abdelhamid Benazzouz and Dr. Bernard Bioulac.
They offer a solution for deep brain surgery simulation currently practiced in the Pellegrin Hospital. This was developed in 1993 by Dr. Christian Gross, DR. Abdelhamid Benazzouz and Dr. Bernard Bioulac.
